Vaxcyte, Inc. (PCVX)
58.13
-2.24
(-3.71%)
USD |
NASDAQ |
Sep 18, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Vaxcyte Market Cap : 8.416B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 8.416B |
| September 17, 2026 | 8.741B |
| September 16, 2026 | 8.509B |
| September 15, 2026 | 8.573B |
| September 14, 2026 | 8.621B |
| September 11, 2026 | 8.610B |
| September 10, 2026 | 8.528B |
| September 09, 2026 | 8.616B |
| September 08, 2026 | 8.739B |
| September 04, 2026 | 8.855B |
| September 03, 2026 | 8.857B |
| September 02, 2026 | 8.916B |
| September 01, 2026 | 8.804B |
| August 31, 2026 | 8.794B |
| August 28, 2026 | 8.663B |
| August 27, 2026 | 8.854B |
| August 26, 2026 | 8.845B |
| August 25, 2026 | 8.845B |
| August 24, 2026 | 8.958B |
| August 21, 2026 | 9.066B |
| August 20, 2026 | 8.881B |
| August 19, 2026 | 9.165B |
| August 18, 2026 | 8.657B |
| August 17, 2026 | 8.719B |
| August 14, 2026 | 8.408B |
| Date | Value |
|---|---|
| August 13, 2026 | 8.522B |
| August 12, 2026 | 8.636B |
| August 11, 2026 | 8.574B |
| August 10, 2026 | 8.440B |
| August 07, 2026 | 8.408B |
| August 06, 2026 | 8.526B |
| August 05, 2026 | 8.096B |
| August 04, 2026 | 7.918B |
| August 03, 2026 | 7.750B |
| July 31, 2026 | 7.805B |
| July 30, 2026 | 8.076B |
| July 29, 2026 | 7.646B |
| July 28, 2026 | 7.880B |
| July 27, 2026 | 8.009B |
| July 24, 2026 | 7.888B |
| July 23, 2026 | 8.030B |
| July 22, 2026 | 8.082B |
| July 21, 2026 | 8.376B |
| July 20, 2026 | 8.009B |
| July 17, 2026 | 8.111B |
| July 16, 2026 | 8.087B |
| July 15, 2026 | 8.188B |
| July 14, 2026 | 8.112B |
| July 13, 2026 | 8.230B |
| July 10, 2026 | 8.401B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 61.46B |
| Arrowhead Pharmaceuticals, Inc. | 9.383B |
| Oncolytics Biotech, Inc. | 95.97M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.124B |
Market Cap Related Metrics
| PEG Ratio | -0.0899 |
| Price to Book Value | 3.052 |
| Price | 58.13 |
| Earnings Yield | -13.26% |
| PEGY Ratio | -0.0899 |